DNAPrint Genomics Inc
OTC:DNAG
Cash Flow Statement
Cash Flow Statement
DNAPrint Genomics Inc
| Dec-2005 | Mar-2006 | Jun-2006 | Sep-2006 | Dec-2006 | Mar-2007 | Jun-2007 | Sep-2007 | ||
|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||
| Net Income |
(9)
|
(11)
|
(11)
|
(13)
|
(12)
|
(7)
|
(6)
|
(5)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
|
| Other Non-Cash Items |
4
|
4
|
4
|
4
|
4
|
(1)
|
(1)
|
(1)
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
1
|
1
|
0
|
1
|
2
|
2
|
3
|
1
|
|
| Cash from Operating Activities |
(4)
N/A
|
(5)
-39%
|
(6)
-25%
|
(6)
-2%
|
(6)
+10%
|
(5)
+15%
|
(4)
+19%
|
(4)
-3%
|
|
| Investing Cash Flow | |||||||||
| Capital Expenditures |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Items |
(2)
|
(2)
|
(0)
|
0
|
1
|
3
|
5
|
6
|
|
| Cash from Investing Activities |
(2)
N/A
|
(2)
-5%
|
(0)
+81%
|
(0)
+84%
|
0
N/A
|
2
+1 249%
|
4
+92%
|
6
+34%
|
|
| Financing Cash Flow | |||||||||
| Net Issuance of Common Stock |
4
|
6
|
5
|
4
|
3
|
2
|
1
|
1
|
|
| Net Issuance of Debt |
2
|
2
|
2
|
2
|
1
|
1
|
(2)
|
(3)
|
|
| Other |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
7
N/A
|
7
+10%
|
8
+4%
|
6
-16%
|
4
-31%
|
2
-46%
|
(1)
N/A
|
(2)
-40%
|
|
| Change in Cash | |||||||||
| Effect of Foreign Exchange Rates |
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
(0)
|
|
| Net Change in Cash |
1
N/A
|
(0)
N/A
|
1
N/A
|
(0)
N/A
|
(1)
-634%
|
(0)
+70%
|
(1)
-126%
|
0
N/A
|
|
| Free Cash Flow | |||||||||
| Free Cash Flow |
(4)
N/A
|
(5)
-41%
|
(6)
-23%
|
(7)
-4%
|
(6)
+8%
|
(5)
+15%
|
(4)
+18%
|
(4)
-1%
|
|